Drug Topics

MAY 27, 2025

Researchers explored how relationships between physicians, pharmacists, and patients are associated with the use of generic drugs in Japanese pharmacies.

Hospitals 341

Hospitals 341

Pharmacy Times

MAY 12, 2025

A panelist discusses how physicians can collaborate with community pharmacists to enhance respiratory syncytial virus (RSV) vaccine uptake by leveraging pharmacists' expertise in patient education, addressing vaccine hesitancy through empathetic communication, and emphasizing the safety, benefits, and risks of RSV vaccination.

Vaccines 65

Vaccines Communication 65

The FDA Law Blog

MAY 19, 2025

By Larry K. Houck Last month the U.S. Attorneys Office for the Northern District of Illinois announced that Walgreens agreed to pay up to $350,000,000 to resolve allegations that its pharmacies illegally filled millions of invalid prescriptions for opioids and other controlled substances in violation of the federal Controlled Substances Act, and sought payment for filling many of those prescriptions by federal health care programs, violating the False Claims Act.

Controlled Substances 65

Controlled Substances Dosage Insurance 65

Hospital Pharmacy Europe

MAY 27, 2025

Patients gender, age and ethnicity significantly influence the likelihood of having a medication-related error formally reported, according to a cross-sectional study by Barts Health NHS Trust in London, UK. The findings of this first report assessing possible disparities in medicine-related incident reporting in England highlight that systematic support is required to reduce the variation of medicine error reporting among patients with key protected characteristics.

Compounding 52

Compounding Hospitals 52

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

The Checkup by Singlecare

MAY 6, 2025

Zinc is an essential nutrient for many bodily processes, such as immune function and wound healing. Your body doesnt naturally produce it, so you must consume it in the foods you eat or take a supplement to avoid a zinc deficiency. Luckily, many foods you probably already eat are chock-full of zinc, including seafood, red meat, poultry, whole grains, and legumes.

Immunization 85

Immunization Mayo Clinic Dosage 85

Pharmaceutical Technology

MAY 27, 2025

The deal tees up a pain treatment market rivalry with Vertex Pharmaceuticals as the industry starts to move away from opioids.

97

97

Pharmacy Times

MAY 12, 2025

A panelist discusses how physicians can navigate respiratory syncytial virus (RSV) vaccine selection by considering patient age, pregnancy status, and seasonality, highlighting the approved indications for Arexvy and Abrysvo, including maternal immunization to protect infants through passive immunity.

Vaccines 65

Vaccines Immunization 65

Pharma Marketing Network

MAY 27, 2025

In an era where digital voices influence everything from fashion to finance, its natural to ask: does influencer marketing work in pharma? Traditionally conservative and heavily regulated, the pharmaceutical industry is now exploring new ways to connect with patients, caregivers, and healthcare professionals. As consumer behavior continues to shift online, pharma marketers are evaluating whether social influencers can play a trusted role in driving engagement, education, and even brand loyalty.

FDA 59

FDA Communication 59

DiversifyRx

MAY 28, 2025

Let’s be honestsome leaders make it to the top despite themselves. Case in point: Jerry Jones. Sure, the man knows how to build a billion-dollar brand, but when it comes to leadership? Oof. The Dallas Cowboys owner has become the ultimate case study in what not to do. Decades of micromanaging, ego-driven decisions, and resistance to change have kept “America’s Team” from reaching its full potential.

Communication 52

Communication 52

The Checkup by Singlecare

MAY 28, 2025

Adderall is a brand-name prescription drug best known for treating attention deficit hyperactivity disorder (ADHD). However, Adderall and its generic version (the active ingredients amphetamine and dextroamphetamine) are also FDA-approved for the treatment of narcolepsy. Both brand-name and generic Adderall are also available in immediate-release (IR) and extended-release (ER) forms.

Insurance 59

Insurance Insurance Coverage Health Insurance Companies FDA 59

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

MAY 28, 2025

InflaRx has abandoned its drug development programme, vilobelimab for rare skin disease pyoderma gangrenosum, cratering its share price.

78

78

Drug Topics

MAY 27, 2025

Mitchell Barnett, PharmD, MS, discusses what lessons can be learned from a community pharmacy drug disposal program.

Community Pharmacies 432

Community Pharmacies 432

Pharmacy Times

MAY 12, 2025

PharmStart empowers pharmacy technicians to pursue their education with tuition-free prerequisites, addressing barriers to entering pharmacy school.

69

69

Fierce Healthcare

MAY 12, 2025

The already massive nonprofit has grown substantially since the start of last year, though its operating performance and bottom line were both down.

66

66

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

STAT

MAY 24, 2025

Florida has just banned fluoride in public water , becoming the second state to do so. It’s part of decadeslong battle that has heated up in recent years. Local governments debate whether it belongs in the water supply. Parents question safety. Pseudoscience clouds public perception. Often, the conversation is framed as a domestic ideological battle between personal liberty and public health mandates.

145

145

Pharmafile

MAY 6, 2025

Sanofi and Clayton, Dubilier & Rice (CD&R) have officially closed the sale of a controlling 50% stake in Opella, Sanofis consumer healthcare division, positioning Opella as a new independent leader in the global consumer health space. The deal brings Sanofi approximately 10bn in net cash proceeds. Sanofi retains a 48.2% share in Opella, with Bpifrance […] The post Sanofi and CD&R finalise Opella deal, launching global consumer healthcare giant appeared first on Pharmafile.

100

100

pharmaphorum

MAY 27, 2025

Roche is moving its antibiotic zosurabalpin into phase 3 for CRAB, potentially a big step forward in the fight against antimicrobial resistance

114

114

Drug Topics

MAY 18, 2025

Researchers conducted a clinical review detailing the intersection of dermatology and suicide, explaining why skin conditions lead to increased risk of poor mental health.

492

492

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

MAY 12, 2025

Panelists discuss how evidence from a value-based care perspective demonstrates long-term health benefits, including reduced recurrent events and hospitalizations, as well as cost savings associated with intensive low-density lipoprotein cholesterol (LDL-C)lowering therapies beyond statins in patients who are very high-risk post-atherosclerotic cardiovascular disease (ASCVD), while also addressing key challenges health care providers face in selecting nonstatin therapies and strategies to overco

Hospitals 65

Hospitals 65

The Checkup by Singlecare

MAY 27, 2025

As a blood thinner or anticoagulant, Xarelto plays a pivotal role in preventing stroke in atrial fibrillation. Known as AFib, this condition is the most prevalent heart rhythm problem requiring treatment. The atria or top chambers of the heart beat erratically rather than rhythmically, and as a result, the ventricles or bottom pumping chambers beat erratically too.

Labelling 52

Labelling FDA 52

Blog: Ask a Student Pharmacist

MAY 27, 2025

Jamie Chen: Chemistry and connection within pharmacy eomizowh Tue, 05/27/2025 - 09:39 Author: Erin Wilson Second-year PharmD student Jamie Chens love for chemistry and human connection led her north to the University of Minnesota College of Pharmacy. While pursuing her undergraduate degree in chemistry, she shadowed pharmacists at an independent pharmacy in Arkansas, her home state, keeping the experience in her back pocket as she explored her options.

Independent Pharmacies 52

Independent Pharmacies 52

Pharma Marketing Network

MAY 18, 2025

Imagine youre trying to reach a specialist in a bustling hospitalyour message is a whisper in a sea of noise. How do you get through? In the complex world of healthcare, pharmaceutical marketing strategies must evolve to genuinely connect with healthcare professionals (HCPs). No longer effective are blanket tactics or generic messaging. Instead, today’s successful marketers are leveraging personalized, data-driven, and omnichannel approaches that meet HCPs where they are.

Health and Personal Care Stores 52

Health and Personal Care Stores HIPAA Communication 52

STAT

MAY 13, 2025

For a recent therapy session, Andria Donaghy’s insurance plan paid her psychiatric nurse practitioner only $11 on a $125 service.  “To even put that on paper is insulting,” she said. “These people give their lives [to help others] and that’s what you pay them?

Insurance 130

Insurance 130

Drug Topics

MAY 13, 2025

Pharmacist-led interventions improve medication adherence compared with the usual care for patients with heart failure and type 2 diabetes.

281

281

Pharmacy Times

MAY 18, 2025

Naxitamab-gqgk has been added as a Category 2A recommendation in the updated National Comprehensive Cancer Network (NCCN) guidelines for high-risk neuroblastoma, reflecting growing consensus on its role in treating relapsed or refractory disease.

65

65

European Pharmaceutical Review

MAY 5, 2025

New clinical findings show that Johnson & Johnsons monoclonal antibody Tremfya (guselkumab) enabled sustained clinical and endoscopic efficacy for ulcerative colitis patients at two years. This is based on the long-term extension study of the Phase III QUASAR trial , which evaluated adults with moderately-to-severely active forms of the disease.

FDA 64

FDA 64

Pharmafile

MAY 28, 2025

TQ Therapeutics (TQx) has acquired Juno Therapeutics GmbH, the German subsidiary of Juno Therapeutics, through a share purchase agreement. Juno GmbH was previously owned by Bristol Myers Squibb. Financial terms have not been disclosed. The acquisition expands TQxs access to intellectual property and licensing agreements that will support the development of its decentralised, automated cell […] The post TQ Therapeutics acquires Juno GmbH to support decentralised cell therapy platform appear

59

59

Pharma Marketing Network

MAY 29, 2025

AI is rapidly transforming the digital marketing landscape, and nowhere is this more evident than in the evolution of search behavior. With tools like ChatGPT, Bing Copilot, and Googles AI Overviews influencing how users discover and engage with content, pharma marketers are being challenged to rethink traditional metrics. So how can you actually track inbound AI search traffic?

52

52

STAT

MAY 9, 2025

Less than two years ago, I completed a three-year emergency medicine residency and, after passing written and oral board exams, became a board-certified emergency physician. Now, the Accreditation Council for Graduate Medical Education is claiming that three years of personal and financial sacrifice are not enough.  The ACGME reviews each specialty’s program requirements every 10 years, and it recently released their proposed updates for emergency medicine.

Hospitals 105

Hospitals 105

Drug Topics

MAY 14, 2025

Investigators also find that patients diagnosed with type 1 diabetes later in life do not have a better prognosis compared to those diagnosed earlier.

380

380

Pharmacy Times

MAY 13, 2025

FDA and CDC halt Ixchiq chikungunya vaccine for adults 60 years and older due to severe adverse events, including fatalities, urging caution in vaccination practices.

Vaccines 65

Vaccines FDA 65

PharmExec

MAY 6, 2025

Blake Powers, CEO, medigi, explains how digital tools, AI, and automation are streamlining access to biosimilars and cell and gene therapies, signaling a shift toward more tech-enabled, patient-centric care.

52

52

European Pharmaceutical Review

MAY 5, 2025

Drug delivery technology is undergoing rapid innovation worldwide. Pharmaceutical manufacturers are adopting advanced delivery platforms to improve drug efficacy and patient compliance, while scaling production for global distribution. In fact, industry analysis shows drug delivery innovation is at an all-time high globally. From nanotechnology-based carriers to smart inhalation devices, these developments are reshaping how therapies are manufactured and administered.

89

89